Favresse Diagnostics SRL
Favresse Diagnostics reported total assets of 418,707 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of Favresse Diagnostics shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -99 % Total assets +46 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Favresse Diagnostics's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 302,908 € | ||||
| Equity | 1,655 € | ||||
| Cash | 236,294 € | ||||
| EBITDA | 412,362 € | ||||
| Total assets | 418,707 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 15 Jul 2024
- Year ended 31 Dec 2022filed on 18 Jul 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Favresse Diagnostics's financial analysis
- Solvency0.4%sector median: 66.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Favresse Diagnostics
Favresse Diagnostics's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0760.571.951
- VAT number
- BE0760571951
- Peppol
- Registered · 0208:0760571951 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Dec 2020
- Registered office
- 1367 Ramillies
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
Favresse Diagnostics (SRL) has been based in Ramillies since 2020, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports a net profit of 302,908 € and equity of 1,655 €; its revenue is not published. Its solvency stands at 0.4%, below the median of its sector (66.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Favresse Diagnostics
Companies in the same business, of comparable size and area, outside its group.
- Saryam Manufacture of basic pharmaceutical products Ittre · balance sheet 418,598 €
- Francoise DISCRY Market research and public opinion polling Esneux · balance sheet 418,433 €
- Infirmière Songue et fils Nursing and midwifery activities Éghezée · balance sheet 419,029 €
- Black Liège · balance sheet 418,810 €
Frequently asked questions about Favresse Diagnostics
What is the revenue of Favresse Diagnostics?
Favresse Diagnostics files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Favresse Diagnostics?
In Belgium, the VAT number is the company number prefixed with BE: BE0760571951 for Favresse Diagnostics, if the company is VAT-registered. Its company number (CBE) is 0760.571.951.
Where is the registered office of Favresse Diagnostics?
According to the CBE register, the registered office of Favresse Diagnostics is in 1367 Ramillies.
What is the equity of Favresse Diagnostics?
At the close of the 2025 financial year, the equity of Favresse Diagnostics amounts to 1,655 €, a solvency of 0.4% of total assets.
Who manages Favresse Diagnostics?
The register lists 1 active mandates at Favresse Diagnostics. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Favresse Diagnostics
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →